Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 1
1(25.0%)
4Total
N/A(3)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07480603Phase 1Active Not Recruiting

Pilot Study on a New Self Adjustable Glaucoma Drainage Device

Role: lead

NCT05912790Not ApplicableUnknown

eyeTube in Combination With the eyeWatch Implant

Role: lead

NCT03210571Not ApplicableCompleted

Clinical Investigation of the eyeWatch Glaucoma Drainage Device

Role: lead

NCT02554214Not ApplicableUnknown

Pilot Clinical Trial on a New Adjustable Glaucoma Drainage Device

Role: lead

All 4 trials loaded